The AGES Society Research Fund has been the principal provider of gynaecological surgery research funding in Australasia for 22 years. During this time, more than $1,750,000 has been granted to over 128 research projects with an ongoing commitment to support research that leads to improvements in women’s health.
Key Dates
Submissions open for the 2027 round of funding – 31 July 2026
Submissions Close for the 2027 round of funding – 30 September 2026
Application Categories
Applications will be accepted from current AGES members in the following categories:
Fellows - Call for Submissions
Trainees & Young Fellows - Call for Submissions
Trainee Research: Metanalysis or Literary Review - Call for Submissions
*These documents are all in the 'supporting documents' section of this page.
Application Process
You can start the application process at any time. Use the application link to log into your Currinda profile and start your submission. You can make additions and changes to your grant application right up until the submission deadline.
When you start your application, you will be asked to submit the following details:
Please ensure all documents are uploaded as PDF.
Review Process
The AGES Society Research Committee is an independent committee, separate to the AGES Board, that is charged with assessing applications and allocating grants. The committee are chosen carefully to cover a wide range of expertise and to ensure representation from across Australia and New Zealand.
If there is a conflict of interest between a reviewer and an applicant, the COI is recorded and the submission is reviewed by a different committee member. Any committee member with a COI abstains from voting on that submission during the final review meeting.
The review process begins once the application deadline has passed.
1. The applications are collated and checked against known COI of the committee.
2. The submissions are then evenly allocated to committee members.
3. If a COI is then reported by a committee member the application is reassigned.
4. Each application is reviewed individually by two committee members, with no two applications reviewed by the same two members.
All applications are assessed using the following categories:
The full scoring rubric is available in the supporting documents below. All applications, both successful and unsuccessful will receive a copy of their marked scoring rubric with their results letter.
After the initial review, all scores are checked. If the scoring from two reviewers is contradictory, a third reviewer is assigned.
The committee then meets to discuss each of the applications and make a recommendation to the AGES board for final approval of funding selection.
This is the most important fit factor.
AGES was established around education, surgical training and clinical research in gynaecological endoscopy and surgery. The Society particularly emphasizes minimally invasive approaches including:
A general obstetrics/gynaecology research project without a meaningful surgical component would therefore be a weaker AGES fit.
This is explicitly one of the review categories used by the AGES Society Research Committee.
A competitive proposal should clearly demonstrate:
Important clinical problem → evidence gap → research question → potential improvement in surgical care.
Strong questions might address:
The project should be important not merely because it is technically interesting, but because it could improve patient care.
AGES explicitly scores the validity of the scientific approach.
This means the proposal needs more than an interesting surgical idea.
It should include:
For example:
Surgical technique A vs B → postoperative outcomes → complications → recovery → quality of life
is much stronger than simply describing outcomes after introducing a new procedure.
Feasibility is explicitly scored by AGES reviewers.
This should be demonstrated through:
The strongest proposal is one where reviewers can immediately see:
“This team can actually complete this study.”
AGES' overarching vision is to improve gynaecological health, with particular emphasis on safe and high-quality clinical and minimally invasive surgical care for women.
Therefore, proposals should connect their research to outcomes such as:
The track record of the investigator is explicitly included in the AGES scoring framework.
Reviewers are therefore likely to consider whether the applicant has:
However, this does not mean that only senior researchers are competitive.
AGES has separate application categories for:
This provides a meaningful route for early-career investigators.
AGES explicitly evaluates the availability of expertise and facilities.
A proposal should identify:
For trainee applications, the supervising gynaecologist/FRANZCOG supervisor is part of the application information requested by AGES.
AGES emphasizes innovation and the evaluation of evidence-based surgery. Its stated vision includes improving women's health through research, surgery and advocacy.
Potentially strong innovative topics include:
Minimally invasive surgery
Surgical technology
Surgical outcomes
Innovation should remain clinically meaningful, rather than simply introducing technology.
AGES explicitly evaluates the appropriateness of the budget.
The budget should be:
For a smaller research grant, a highly focused project with a modest budget is preferable to a broad study requiring resources far beyond the award.
This is explicitly one of the seven assessment categories.
This effectively means the proposal must answer:
Why should AGES, specifically, fund this project?
A good answer would be:
The project addresses a significant gynaecological surgical problem, evaluates an evidence-based or innovative minimally invasive approach, is feasible within the proposed resources, and has potential to improve surgical outcomes for women.
Eligible Countries:
Sponsor Institute/Organizations: Australasian Gynaecological Endoscopy & Surgery Society
Sponsor Type: Corporate/Non-Profit
Address: PO Box 717 Indooroopilly QLD 4068
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 30, 2026
Sep 30, 2026
$1,750,000
Affiliation: Australasian Gynaecological Endoscopy & Surgery Society
Address: PO Box 717 Indooroopilly QLD 4068
Website URL: https://ages.com.au/resources/research-grants/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.